As of Apr 17
| -0.98 / -1.48%|
The 10 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 71.50, with a high estimate of 80.00 and a low estimate of 10.00. The median estimate represents a +9.44% increase from the last price of 65.33.
The current consensus among 12 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.